GLOBAL CORD BLOOD CORP (CO)       2.9876  +0.77 (+34.58%)

2.9876  +0.77 (+34.58%)

KYG393421030 - Common Stock - Premarket: 2.925 -0.06 (-2.1%)

News Image
4 months ago - Global Cord Blood Corporation

Global Cord Blood Corporation Files Annual Report on Form 20-F

/PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing,...

News Image
5 months ago - Global Cord Blood Corporation

Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGM

/PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO, "GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing,...

News Image
5 months ago - Global Cord Blood Corporation

Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022

/PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing,...

News Image
6 months ago - Global Cord Blood Corporation

Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis

/PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing,...

News Image
7 months ago - Blue Ocean Structure Investment Company Ltd.

Blue Ocean Successfully Applied Injunction to Stop Global Cord Blood from Acquiring Cellenkos Following Cayman Islands Court Ruling

/PRNewswire/ -- Blue Ocean Structure Investment Company Ltd. ("Blue Ocean"), a significant shareholder of Global Cord Blood Corporation (the "Company" or...

News Image
7 months ago - Global Cord Blood Corporation

Global Cord Blood Corporation Announces Receipt of Blue Ocean Petition

/PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO, "GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing,...

News Image
7 months ago - Blue Ocean Structure Investment Company Ltd.

Blue Ocean Urges Shareholders of Global Cord Blood Corporation to Join Forces to Terminate its Proposed Acquisition of Cellenkos Inc

/PRNewswire/ -- Blue Ocean Structure Investment Company Ltd., together with its affiliates ("Blue Ocean"), is a significant shareholder of Global Cord Blood...

News Image
7 months ago - Global Cord Blood Corporation

Global Cord Blood Corporation Announces Entry into Cell Therapy Market by Acquiring Cellenkos and Its Products Rights

/PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO, "GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing,...